Articles with public access mandates - Fangya TanLearn more
Available somewhere: 3
Elucidation of the application of blood test biomarkers to predict immune-related adverse events in atezolizumab-treated NSCLC patients using machine learning methods
JG Zhou, AHH Wong, H Wang, F Tan, X Chen, SH Jin, SS He, G Shen, ...
Frontiers in Immunology 13, 862752, 2022
Mandates: National Natural Science Foundation of China
Definition of a new blood cell count (BCT) score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of 4 …
JG Zhou, AHH Wong, H Wang, SH Jin, F Tan, YZ Chen, SS He, G Shen, ...
medRxiv, 2021.08. 28.21262770, 2021
Mandates: National Natural Science Foundation of China
Definition of a new blood cell count score for early survival prediction for non-small cell lung cancer patients treated with atezolizumab: Integrated analysis of four …
JG Zhou, AHH Wong, H Wang, SH Jin, F Tan, YZ Chen, SS He, G Shen, ...
Frontiers in Immunology 13, 961926, 2022
Mandates: National Natural Science Foundation of China
Publication and funding information is determined automatically by a computer program